Report Detail
Global Ibrexafungerp Citrate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4702038 |
- 01 June, 2026 |
- Global |
- 84 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Ibrexafungerp Citrate Tablets market size was valued at US$ 309 million in 2025 and is forecast to a readjusted size of US$ 1003 million by 2032 with a CAGR of 11.0% during review period.
Ibrexafungerp Citrate is a novel triterpenoid antifungal agent that exerts fungicidal effects by inhibiting the synthesis of β‑1,3‑glucan in fungal cell walls. It demonstrates potent activity against a variety of pathogenic fungi including Candida species. Administered as an oral tablet in its citrate salt form, it is mainly indicated for the treatment of vulvovaginal candidiasis and can also be used for the prophylaxis and management of invasive fungal infections. With favorable oral absorption, broad antifungal spectrum and good safety profile, it represents a valuable new option for clinical antifungal therapy.
In 2025, global ibrexafungerp citrate production reached approximately 2.1–2.3 million bottles
As the first-in-class oral triterpenoid antifungal drug worldwide, ibrexafungerp citrate holds an important innovative position in the global antifungal market due to its unique mechanism of action, broad-spectrum antifungal activity and favorable safety profile. It is mainly indicated for the treatment and prevention of vulvovaginal candidiasis and recurrent infections, while expanding its indications to areas such as invasive fungal infections. Its market growth is driven by rising global incidence of fungal diseases, increasing drug-resistant strains and limitations of existing therapies. With its differentiated advantages, it complements traditional azoles and echinocandins, showing growth potential in both gynecological anti-infective and systemic antifungal segments. Global commercialization is carried out through collaboration between innovator companies and regional partners. The approval and launch in emerging markets including China has further unlocked incremental space. Despite challenges such as pricing, insurance coverage and market education, the market continues to expand steadily with patent protection, expanded indications and improved clinical recognition, supporting continuous enhancement of long-term market value and competitiveness.
This report is a detailed and comprehensive analysis for global Ibrexafungerp Citrate Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ibrexafungerp Citrate Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ibrexafungerp Citrate Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ibrexafungerp Citrate Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ibrexafungerp Citrate Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ibrexafungerp Citrate Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ibrexafungerp Citrate Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Scynexis, GlaxoSmithKline, Hansoh Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ibrexafungerp Citrate Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablets
For Oral Suspension
Market segment by Combination Therapy
Combination With Azole Antifungals
Combination With Echinocandins
Market segment by Sales Channels
Hospitals
Retail
Online
Market segment by Application
Vulvovaginal Candidiasis
Recurrent Vulvovaginal Candidiasis
Invasive Fungal Infections
Others
Major players covered
Scynexis
GlaxoSmithKline
Hansoh Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ibrexafungerp Citrate Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ibrexafungerp Citrate Tablets, with price, sales quantity, revenue, and global market share of Ibrexafungerp Citrate Tablets from 2021 to 2026.
Chapter 3, the Ibrexafungerp Citrate Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ibrexafungerp Citrate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ibrexafungerp Citrate Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ibrexafungerp Citrate Tablets.
Chapter 14 and 15, to describe Ibrexafungerp Citrate Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ibrexafungerp Citrate Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Tablets
- 1.3.3 For Oral Suspension
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Ibrexafungerp Citrate Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Combination With Azole Antifungals
- 1.4.3 Combination With Echinocandins
- 1.5 Market Analysis by Sales Channels
- 1.5.1 Overview: Global Ibrexafungerp Citrate Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospitals
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Ibrexafungerp Citrate Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Vulvovaginal Candidiasis
- 1.6.3 Recurrent Vulvovaginal Candidiasis
- 1.6.4 Invasive Fungal Infections
- 1.6.5 Others
- 1.7 Global Ibrexafungerp Citrate Tablets Market Size & Forecast
- 1.7.1 Global Ibrexafungerp Citrate Tablets Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Ibrexafungerp Citrate Tablets Sales Quantity (2021-2032)
- 1.7.3 Global Ibrexafungerp Citrate Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Scynexis
- 2.1.1 Scynexis Details
- 2.1.2 Scynexis Major Business
- 2.1.3 Scynexis Ibrexafungerp Citrate Tablets Product and Services
- 2.1.4 Scynexis Ibrexafungerp Citrate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Scynexis Recent Developments/Updates
- 2.2 GlaxoSmithKline
- 2.2.1 GlaxoSmithKline Details
- 2.2.2 GlaxoSmithKline Major Business
- 2.2.3 GlaxoSmithKline Ibrexafungerp Citrate Tablets Product and Services
- 2.2.4 GlaxoSmithKline Ibrexafungerp Citrate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 GlaxoSmithKline Recent Developments/Updates
- 2.3 Hansoh Pharma
- 2.3.1 Hansoh Pharma Details
- 2.3.2 Hansoh Pharma Major Business
- 2.3.3 Hansoh Pharma Ibrexafungerp Citrate Tablets Product and Services
- 2.3.4 Hansoh Pharma Ibrexafungerp Citrate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Hansoh Pharma Recent Developments/Updates
3 Competitive Environment: Ibrexafungerp Citrate Tablets by Manufacturer
- 3.1 Global Ibrexafungerp Citrate Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Ibrexafungerp Citrate Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Ibrexafungerp Citrate Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Ibrexafungerp Citrate Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Ibrexafungerp Citrate Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Ibrexafungerp Citrate Tablets Manufacturer Market Share in 2025
- 3.5 Ibrexafungerp Citrate Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Ibrexafungerp Citrate Tablets Market: Region Footprint
- 3.5.2 Ibrexafungerp Citrate Tablets Market: Company Product Type Footprint
- 3.5.3 Ibrexafungerp Citrate Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ibrexafungerp Citrate Tablets Market Size by Region
- 4.1.1 Global Ibrexafungerp Citrate Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Ibrexafungerp Citrate Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Ibrexafungerp Citrate Tablets Average Price by Region (2021-2032)
- 4.2 North America Ibrexafungerp Citrate Tablets Consumption Value (2021-2032)
- 4.3 Europe Ibrexafungerp Citrate Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Ibrexafungerp Citrate Tablets Consumption Value (2021-2032)
- 4.5 South America Ibrexafungerp Citrate Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Ibrexafungerp Citrate Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Ibrexafungerp Citrate Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Ibrexafungerp Citrate Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Ibrexafungerp Citrate Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Ibrexafungerp Citrate Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Ibrexafungerp Citrate Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Ibrexafungerp Citrate Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Ibrexafungerp Citrate Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Ibrexafungerp Citrate Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Ibrexafungerp Citrate Tablets Market Size by Country
- 7.3.1 North America Ibrexafungerp Citrate Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Ibrexafungerp Citrate Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Ibrexafungerp Citrate Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Ibrexafungerp Citrate Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Ibrexafungerp Citrate Tablets Market Size by Country
- 8.3.1 Europe Ibrexafungerp Citrate Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Ibrexafungerp Citrate Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Ibrexafungerp Citrate Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Ibrexafungerp Citrate Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Ibrexafungerp Citrate Tablets Market Size by Region
- 9.3.1 Asia-Pacific Ibrexafungerp Citrate Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Ibrexafungerp Citrate Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Ibrexafungerp Citrate Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Ibrexafungerp Citrate Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Ibrexafungerp Citrate Tablets Market Size by Country
- 10.3.1 South America Ibrexafungerp Citrate Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Ibrexafungerp Citrate Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Ibrexafungerp Citrate Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Ibrexafungerp Citrate Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Ibrexafungerp Citrate Tablets Market Size by Country
- 11.3.1 Middle East & Africa Ibrexafungerp Citrate Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Ibrexafungerp Citrate Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Ibrexafungerp Citrate Tablets Market Drivers
- 12.2 Ibrexafungerp Citrate Tablets Market Restraints
- 12.3 Ibrexafungerp Citrate Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ibrexafungerp Citrate Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ibrexafungerp Citrate Tablets
- 13.3 Ibrexafungerp Citrate Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ibrexafungerp Citrate Tablets Typical Distributors
- 14.3 Ibrexafungerp Citrate Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ibrexafungerp Citrate Tablets. Industry analysis & Market Report on Ibrexafungerp Citrate Tablets is a syndicated market report, published as Global Ibrexafungerp Citrate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ibrexafungerp Citrate Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
